{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:20:51Z","timestamp":1648696851096},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,9,1]]},"DOI":"10.1093\/ajhp\/56.17.1695a","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T21:38:53Z","timestamp":1550871533000},"page":"1695-1695","source":"Crossref","is-referenced-by-count":0,"title":["Spironolactone an important addition to heart-failure treatment, study shows"],"prefix":"10.1093","volume":"56","author":[{"given":"Jane L.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/56\/17\/1695\/28414091\/ajhp1695a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T07:05:09Z","timestamp":1555311909000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/56\/17\/1695\/5159407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9,1]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[1999,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/56.17.1695a","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,9,1]]},"published":{"date-parts":[[1999,9,1]]}}}